Skip to main content
Premium Trial:

Request an Annual Quote

ChemAxon Tapped to Provide Software for European Drug Discovery Consortium

Premium

ChemAxon said recently that it will provide cheminformatics software for the European Lead Factory, an international consortium of 30 partners that provides access to small molecules and compounds that could be used to develop new medicines.

Specifically, ChemAxon will use components of its JChem Base, Discovery, and Marvin toolkits to build a portal through which the consortium will be able to track, score, and analyze submitted proposals for new drug compounds.

With an expected budget of about €196 million ($255 million), the European Lead Factory is supported by the Innovative Medicines Initiative and comprises small and medium-sized enterprises, academic institutions, and large pharmaceutical companies. It is developing a compound library that will contain about 500,000 compounds derived from public and private collections, which it will make available to project partners and public organizations.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.